Transcat Stock Price, News & Analysis

Transcat (NASDAQ: TRNS), a leader in test measurement, control and calibration, announced that CEO Lee D. Rudow will retire in March 2026 after 14 years with the company, including over a decade as CEO. Following his retirement, Rudow will transition to an advisory role until 2027 to ensure continuity.

The Board has initiated a search for the next CEO, considering both internal and external candidates. CFO Tom Barbato confirmed strong financial performance and highlighted recent acquisitions of Martin Calibration and Essco, expecting to return to high single-digit Service organic revenue growth in the second half of fiscal 2026.

Transcat (NASDAQ:TRNS) reported strong fiscal Q1 2026 results with significant growth across key metrics. The company achieved consolidated revenue of $76.4 million, up 14.6% year-over-year, with Service revenue increasing 12.3% to $49.1 million and Distribution revenue growing 19% to $27.3 million.

The company's Adjusted EBITDA rose 15.2% to $11.8 million, while Distribution segment achieved record gross margins of 35.2%. Notably, Transcat announced the acquisition of Essco Calibration Laboratory, their largest deal to date, which adds $22 million in annual revenue and strengthens their presence in the New England market.

To support growth initiatives, Transcat secured a new 5-Year $150 Million syndicated credit facility, nearly doubling their previous capacity. The company maintains a strong balance sheet with a 0.82x leverage ratio and expects high single-digit organic revenue growth in the second half of fiscal 2026.

Transcat (NASDAQ: TRNS) has completed its largest-ever acquisition, purchasing Essco Calibration Laboratory for $84 million in cash. Essco, an ISO-17025 Accredited calibration laboratory based in the Boston metro area, generates over $22 million in annual revenue with EBITDA margins exceeding 25%.

The strategic acquisition positions Transcat as the dominant player in New England's calibration services market. Essco brings 113 employees and serves various sectors including Medical, Life Science, Aerospace & Defense, and Industrial. The deal was financed through Transcat's new $150 million syndicated credit facility led by M&T Bank and Wells Fargo Bank.

This acquisition follows Transcat's purchase of Martin Calibration in December, with both deals expected to contribute approximately $50 million in annualized revenue focused on core calibration services.

Transcat (NASDAQ: TRNS), a leader in test measurement, control and calibration, has secured a new $150 million syndicated secured credit facility with a 5-year term. The facility is led by M&T Bank and includes Wells Fargo and Bank of America as additional lenders.

The new credit facility, which replaces an existing $80 million facility, includes revolving loan options, swingline loans, and letters of credit. It features enhanced flexibility with a temporary leverage ratio covenant increase for permitted acquisitions. The facility will be used to refinance the previous facility, fund strategic acquisitions, and provide working capital for general corporate purposes.

Transcat (Nasdaq: TRNS), a leader in test measurement, control and calibration, has scheduled its first quarter fiscal year 2026 earnings conference call for Thursday, August 7, 2025, at 11:00 a.m. ET. The company will release its financial results after market close on Wednesday, August 6, 2025.

The conference call will include a discussion of the company's financial results, corporate strategy, and outlook, followed by a Q&A session. Participants can join via toll-free number (800) 267-6316 or international number (203) 518-9783 using Conference ID: TRANSCAT. A webcast replay will be available until August 14, 2025.

Transcat (NASDAQ: TRNS), a leading provider of calibration services and professional test equipment, announced its participation in the upcoming Northland Growth Conference 2025. The virtual event will take place on Wednesday, June 25, 2025, where CEO Lee Rudow, CFO Thomas Barbato, and COO Mike West will conduct one-on-one and small group meetings with investors. The company specializes in accredited calibration services, cost control and optimization services, and distribution and rental of professional-grade handheld test, measurement, and control instrumentation. Interested parties can schedule meetings through Northland Capital Markets representatives or by contacting TRNS@mzgroup.us.

Transcat Inc. (NASDAQ: TRNS), a provider of calibration services and professional test equipment, has announced its participation in the 22nd Annual Craig-Hallum Institutional Investor Conference. The event will take place on May 28, 2025, at the Depot Renaissance Hotel in Minneapolis, Minnesota.

The company's leadership team, including CEO Lee Rudow, CFO Tom Barbato, and COO Mike West, will be available for one-on-one and small group meetings with investors throughout the conference. Interested parties can schedule meetings through their Craig-Hallum representative or by contacting TRNS@mzgroup.us.

Transcat (NASDAQ: TRNS) reported strong financial results for Q4 and full fiscal year 2025. In Q4, Service revenue grew 11.3% to $52 million with a 50 basis point margin expansion to 36.2%, driven by productivity improvements and automation. Total consolidated revenue increased 8.8% to $77.1 million, while Adjusted EBITDA rose 9.1% to $12.7 million. For the full fiscal year 2025, revenue grew 7.3% to $278.4 million. The company maintained a strong balance sheet with a leverage ratio of 0.78 and $49.1 million available for borrowing. Despite macroeconomic uncertainties, Transcat's business model remains resilient, supported by regulatory standards and a diversified Fortune 500 client base.

Transcat (NASDAQ: TRNS) reported strong Q4 fiscal 2025 results with consolidated revenue growing 8.8% to $77.1M. The Service segment revenue increased 11.3% to $52M, driven by $6.8M in acquisition revenue, while Distribution revenue rose 3.9% to $25.1M. Q4 Service gross margins expanded 50 basis points to 36.2% due to improved productivity and automation. Q4 Adjusted EBITDA grew 9.1% to $12.7M. For full fiscal year 2025, total revenue increased 7.3% to $278.4M with growth in both segments. The company maintained a strong balance sheet with $49.1M available for borrowing and a leverage ratio of 0.78. Despite macroeconomic uncertainties, management remains confident in the company's resilient business model and regulatory-driven growth opportunities.